A molecular study of hippocampus in dogs with convulsion during canine distemper virus encephalitis

Brain Research

Volumn 1098, Issue 1, 2006, Pages 186-195

  Giulia, D'Intino ^a   Francesca, Vaccari ^a   Sandra, Sivilia ^a   Alessandra, Scagliarini ^a   Gualtiero, Gandini ^a   Luciana, Giardino ^a   Laura, Calzà ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Brain derived neurotrophic factor; Epilepsy; Glutamate; Nerve growth factor; Neuropeptide

Indexed keywords

GLUTAMATE TRANSPORTER; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SLICE; BRAIN TISSUE; CANINE DISTEMPER MORBILLIVIRUS; CONTROLLED STUDY; CONVULSION; EPILEPTIC STATE; EUTHANASIA; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE THRESHOLD; VIRUS ENCEPHALITIS;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; DISTEMPER; DISTEMPER VIRUS, CANINE; DOGS; ENCEPHALITIS, VIRAL; FEMALE; GENES, FOS; GROWTH SUBSTANCES; HIPPOCAMPUS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEUROPEPTIDES; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEIZURES; STATUS EPILEPTICUS;

ANIMALIA; CANINE DISTEMPER VIRUS; CANIS FAMILIARIS;

EID: 33747789376     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.051     Document Type: Article

References (55)

1. Alreja M., Shanabrough M., Liu W., and Leranth C. Opioids suppress IPSCs in neurons of the rat medial septum/diagonal band of Broca: involvement of mu-opioid receptors and septohippocampal GABAergic neurons. J. Neurosci. 20 (2000) 1179-1189
2. Binder D.K., Croll S.D., Gall C.M., and Scharfman H.E. BDNF and epilepsy: too much of a good thing?. TRENDS Neurosci 24 (2001) 47-53
3. Calzà L., Giardino L., Ceccatelli S., and Hokfelt T. Neurotrophins and their receptors in the adult hypo- and hyperthyroid rat after kainic acid injection: an in situ hybridization study. Eur. J. Neurosci. 8 (1996) 1873-1881
4. Chang B.S., and Lowenstein D.H. Epilepsy. New Engl. J Med. 349 (2003) 1257-1266
5. Cotman C.W., Head E., Muggenburg B.A., Zicker S., and Milgram N.W. Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction. Neurobiol. Aging 23 (2002) 809-818
6. Crino P.B., Jin H., Shumate M.D., Robinson M.B., Coulter D.A., and Brooks-Kayal A.R. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 43 (2002) 211-218
7. Cummings B.J., Head E., Ruehl W., Milgram N.W., and Cotman C.W. The canine as an animal model of human aging and dementia. Neurobiol. Aging 17 (1996) 259-268
8. Dimakopoulos A.C., and Mayer R.J. Aspects of neurodegeneration in the canine brain. J. Nutr. 132 (2003) 1579S-1582S
9. Dragunow M., Peterson M.R., and Robertson H.A. Presence of c-fos-like immunoreactivity in the adult rat brain. Eur. J. Pharmacol. 135 (1987) 113-114
10. Drake C.T., and Milner T.A. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res. 849 (1999) 203-215
11. Gall C. Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers. J. Neurosci. 8 (1988) 1852-1862
12. Gall C. Regulation of brain neurotrophin expression by physiological activity. TiPS 13 (1992) 401-403
13. Gall C.M. Seizure-induced changes in neurotrophin expression: implications for epilepsy. Exp. Neurol. 124 (1993) 150-166
14. Gall C., Lauterborn J., Isackson P., and White J. Seizures, neuropeptide regulation, and mRNA expression in the hippocampus. Prog. Brain Res. 83 (1990) 371-390
15. Goetz, 2003. Textobook of Clinical Neurology, Sauders
16. Haberman R.P., Samulski R.J., and McCown T.J. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat. Med. 9 (2003) 1076-1080
17. Hartmann M., Heumann R., and Lessmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J. 20 (2001) 5887-5897
18. Hasegawa D., Orima H., Fujita M., Nakamura S., Takahashi K., Ohkubo S., Igarashi H., and Hashizume K. Diffusion-weighted imaging in kainic acid-induced complex partial status epilepticus in dogs. Brain Res. 983 (2003) 115-127
19. Head E., and Torp R. Insights into Aβ and presenilin from a canine model of human brain aging. Neurobiol. Disease 9 (2002) 1-10
20. Head E., Thornton P.L., Tong L., and Cotman C.W. Initiation and propagation of molecular cascades in human brain aging: insight from the canine model to promote successful aging. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 24 (2000) 777-786
21. Hodge M.J., and Wolfson C. Canine distemper virus and multiple sclerosis. Neurology. 49 2 Suppl 2 (1997) S62-S69
22. Hughes P., and Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmac. Rev. 47 (1995) 133-178
23. Hughes P.E., Alexi T., Walton M., Williams C.E., Dragunow M., Clark R.G., and Gluckman P.D. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog. Neurobiol. 57 (1999) 421-450
24. Jankowsky J.L., and Patterson P.H. The role of cytokines and growth factors in seizures and their sequelae. Prog. Neurobiol. 63 (2001) 125-149
25. Koestner A. Neuropathology of canine epilepsy. Probl Vet Med. 1 (1989) 516-534
26. Kokaia M., Holmerg K., Nanobashvili A., Xu Z.Q., Kokaia Z., Lendahl U., Hilke S., Theodorsson E., Kahl U., Bartfai T., Lindvall O., and Hokfelt T. Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc. Natl. Acad. Sci. USA 98 (2001) 14006-14011
27. Koutinas A.F., Polizopoulou Z.S., Baumgaertner W., Lekkas S., and Kontos V. Relation of clinical signs to pathological changes in 19 cases of canine distemper encephalomyelitis. J. Comp. Pathol. 126 (2002) 47-56
28. Lin E.J., Richichi C., Young D., Baer K., Vezzani A., and During M.J. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur. J. Neurosci. 18 (2003) 2087-2092
29. Loscher W. Animal models of intractable epilepsy. Prog. Neurobiol. 53 (1997) 239-258
30. Mathern G.W., Mendoza D., Lozada A., Pretorius J.K., Dehnes Y., Danbolt N.C., Nelson N., Leite J.P., Chimelli L., Born D.E., Sakamoto A.C., Assirati J.A., Fried I., Peacock W.J., Ojemann G.A., and Adelson P.D. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurol. 52 (1999) 453-472
31. Mattson M.P., and Camandola S. NF-kB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107 (2001) 247-254
32. Mazarati A.M., Liu H., Soomets U., Sankar R., Shin D., Katsumori H., Langel U., and Wasterlain C.G. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J. Neurosci. 18 (1998) 10070-10077
33. Mazarati A.M., Hohmann J.C., Bacon A., Liu H., Sankar R., Steiner R.A., Wynick D., and Wasterlain C.G. Modulation of hippocampal excitability and seizures by galanin. J. Neurosci. 20 (2000) 6276-6281
34. Mazarati A.M., Langel U., and Bartfai T. Galanin: an endogenous anticonvulsant?. Neuroscientist 7 (2001) 506-517
35. McCormick D.A., and Contreras D. On the cellular and network bases of epileptic seizures. Annu. Rev. Physiol. 63 (2001) 815-846
36. McQuiston A.R., and Saggau P. Mu-opioid receptors facilitate the propagation of excitatory activity in rat hippocampal area CA1 by disinhibition of all anatomical layers. J. Neurophysiol. 90 (2003) 1936-1948
37. Milgram N.W., Head E., Muggenburg B., Holowachuk D., Murphey H., Estrada J., Ikeda-Douglas C.J., Zicker S.C., and Cotman C.W. Landmark discrimination learning in the dog: effects of age, antioxidant fortified food, and cognitive strategy. Neurosci. Biobehav. Rev. 26 (2002) 679-695
38. Morimoto K., Fahnestock M., and Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73 (2004) 1-60
39. Riederer P., Gsell W., Calzà L., Franzek E., Jungkunz G., Jellinger K., Reynolds G.P., Crow T., Cruz-Sanchez F.F., and Beckmann H. Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research. Report from the European Dementia and Schizophrenia Network (BIOMED I). J. Neural Transmission, General Sec. 102 (1995) 255-264
40. Rogawski M.A., and Loscher W. The neurobiology of antiepileptic drugs. Nat. Rev. 5 (2004) 553-564
41. Rong Y., and Baudry M. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J. Neurochem. 67 (1996) 662-668
42. Sandvig A., Berry M., Barrett L.B., Butt A., and Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46 (2004) 225-251
43. Schobesberger M., Zurbriggen A., Summerfield A., Vandevelde M., and Griot C. Oligodendroglial degeneration in distemper: apoptosis or necrosis?. Acta Neuropathol 97 (1999) 279-287
44. Schobesberger M., Zurbriggen A., and Doherr M.G. Demyelination precedes oligodendrocyte loss in canine distemper virus-induced encephalitis. Acta Neuropathol. 103 (2002) 11-19
45. Stallcup W.B. The NG2 proteoglycan: past insights and future prospects, 2002. J Neurocytol. 31 (2002) 423-435
46. Stein V.M., Czub M., Schreiner N., Moore P.F., Vandevelde M., Zurbriggen A., and Tipold A. Microglial cell activation in demyelinating canine distemper lesions. J. Neuroimmunol. 153 (2004) 122-131
47. Stumm R.K., Zhou C., Schulz S., and Hollt V. Neuronal types expressing μ- and δ-opioid receptor mRNA in the rat hippocampal formation. J. Comp. Neurol. 469 (2004) 107-118
48. Switonski M., Szczerbal I., and Nowacka J. The dog genome map and its use in mammalian comparative genomics. J. Appl. Genet. 45 (2004) 195-214
49. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., and Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276 (1997) 1699-16702
50. Tongiorgi E., Armellin M., Giulianini P.G., Bregola G., Zucchini S., Paradiso B., Steward O., Cattaneo A., and Simonato M. Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis. J. Neurosci. 24 (2004) 6842-6852
51. Vandevelde M., and Zurbriggen A. The neurobiology of canine distemper virus infection. Vet. Microbiol. 44 (1995) 271-280
52. Vezzani A., and Granata T. Brain Inflammation in Epilepsy: Experimental and Clinical Evidence. Epilepsia 46 Issue 11 (2005) 1724
53. Won S.J., Ko H.W., Kim E.Y., Park E.C., Huh K., Jung N.P., Choi I., Oh Y.K., Shin H.C., and Gwag B.J. Nuclear factor kappa B-mediated kainate neurotoxicity in the rat and hamster hippocampus. Neuroscience 94 (1999) 83-91
54. Zurbriggen A., Muller C., and Vandevelde M. In situ hybridisation of virulent canine distemper virus in brain tissue, using digoxigenin-labeled probes. Am. J. Vet. Res. 54 (1993) 1457-1461
55. Zurbriggen A., Schmid I., Graber H.U., and Vandevelde M. Oligodendroglial pathology in canine distemper. Acta Neuropathol. 95 (1998) 71-77